Jeff Sears

I help startups launch AI initiatives | Start-Up Investor, Advisor & Mentor | GTM Leader

📍 United States🔄 Updated September 2026💼 3 investments📅 3 years investing🗓 Last invested Sep 2024
VC🌍 United States
3
Total investments
1
Early stage
0
Mid stage
2
Late stage
3y
Years active

Portfolio

3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor/Advisor
Sep 2024
Our mission is to get healthcare providers paid by automating the remediation of their health insurance claim denials. We have created Daniel - our AI platform that utilizes Machine Learning to fix denied claims by analyzing each denial, determining what is wrong, and providing recommended real time fixes to the claim, automatically re-submitting for approval and payment. Our vision: An environment where every healthcare claim denial is processed in real time, efficiently and accurately, allowing providers to dedicate more time to patient care. Using the Red Sky Health program improves revenue by identifying opportunities for chronic care management. This benefits patient care, increases quality scores and generates potential for incentive payments. The use of coding recommendations improves claims accuracy ensuring no over or underbilling.
Investor/Advisor
Mar 2024
We are a clinical artificial intelligence company that will facilitate the diagnosis and monitoring of headache disorders. We were founded in 2017, in which we have relentlessly searched for an EEG biomarker to diagnose migraine. Doctors and scientists have been searching for an EEG test for 85 years. We have achieved, what we consider to be a major breakthrough, 93% accuracy in diagnosing migraine with aura. We are working with great urgency to try to convert this to a commercial machine learning test. The potential market is vast because there are over one billion people in the world with migraines. With timely support, we could be a significant Canadian first. We will be offering a diagnostic and monitoring service. It is called the Machine Learning Test for Migraine or “MLTM”. Monitoring refers to repeat testing, which is expected to become a big part of the business, just as it is for ECG testing for the heart. We will start with migraine and then proceed to other headache disorders. The Company plans to offer various types of tests, each having its own specific set of values to stakeholders. These include, but not limited to, non-emergency diagnosis on non-pain days, diagnosing a headache in-progress, monitoring for improvement or deterioration, disability assessment and severity assessment. Except for the placement of electrodes by a qualified EEG technician, eventually the test, including the report generation to referring doctors, will be automated.
Advisory Board/Investor
Sep 2023
Leveraging cutting-edge artificial intelligence (AI) technology, we have recently pioneered the development of the customizable Online Heart Learning Center featuring HeartPatientAI, revolutionizing how heart patients understand and navigate their conditions and recovery. Our collaboration with CardioSmart, the American College of Cardiology’s patient engagement initiative, underscores our dedication to advancing standards of care. Our patient education platforms with HeartPatientAI include: • CV/CT Surgery (pre- and post-op video and instructions) • Structural Heart (TAVR, MitraClip™, LAA Closure, etc.) • Cath Lab (heart attack, angioplasty/stent, etc.) • Heart Failure (including implantable device management, CardioMEMs, pacemaker, ICD, CRT) • Left Ventricular Assist Device (LVAD) • Diabetes (information and disease management) • General Heart Health Driven by a commitment to innovation, we have expanded our offerings to include solid organ transplant patient education, recognizing the need for tailored support in these complex medical journeys. Our Online Transplant Learning Center with TransplantPatientAI addresses the unique challenges faced by organ transplant recipients, providing them with the tools and knowledge to embark on their lifelong journey with confidence. Our transplant education platforms include: • Lung • Liver • Kidney • Heart (coming in Spring 2025) Through RecoverRite® and our AI-powered education platforms, we are reshaping the landscape of patient care, empowering individuals to take control of their health and ultimately improving outcomes for both patients and healthcare providers. Lets connect and revolutionize healthcare together.
Experience · 8 entries
All (8)
Investments (3)
2024
Investor/Advisor
Sep 2024
Our mission is to get healthcare providers paid by automating the remediation of their health insurance claim denials. We have created Daniel - our AI platform that utilizes Machine Learning to fix denied claims by analyzing each denial, determining what is wrong, and providing recommended real time fixes to the claim, automatically re-submitting for approval and payment. Our vision: An environment where every healthcare claim denial is processed in real time, efficiently and accurately, allowing providers to dedicate more time to patient care. Using the Red Sky Health program improves revenue by identifying opportunities for chronic care management. This benefits patient care, increases quality scores and generates potential for incentive payments. The use of coding recommendations improves claims accuracy ensuring no over or underbilling.
Investor/Advisor
Mar 2024
We are a clinical artificial intelligence company that will facilitate the diagnosis and monitoring of headache disorders. We were founded in 2017, in which we have relentlessly searched for an EEG biomarker to diagnose migraine. Doctors and scientists have been searching for an EEG test for 85 years. We have achieved, what we consider to be a major breakthrough, 93% accuracy in diagnosing migraine with aura. We are working with great urgency to try to convert this to a commercial machine learning test. The potential market is vast because there are over one billion people in the world with migraines. With timely support, we could be a significant Canadian first. We will be offering a diagnostic and monitoring service. It is called the Machine Learning Test for Migraine or “MLTM”. Monitoring refers to repeat testing, which is expected to become a big part of the business, just as it is for ECG testing for the heart. We will start with migraine and then proceed to other headache disorders. The Company plans to offer various types of tests, each having its own specific set of values to stakeholders. These include, but not limited to, non-emergency diagnosis on non-pain days, diagnosing a headache in-progress, monitoring for improvement or deterioration, disability assessment and severity assessment. Except for the placement of electrodes by a qualified EEG technician, eventually the test, including the report generation to referring doctors, will be automated.
2023
Advisory Board/Investor
Sep 2023
Leveraging cutting-edge artificial intelligence (AI) technology, we have recently pioneered the development of the customizable Online Heart Learning Center featuring HeartPatientAI, revolutionizing how heart patients understand and navigate their conditions and recovery. Our collaboration with CardioSmart, the American College of Cardiology’s patient engagement initiative, underscores our dedication to advancing standards of care. Our patient education platforms with HeartPatientAI include: • CV/CT Surgery (pre- and post-op video and instructions) • Structural Heart (TAVR, MitraClip™, LAA Closure, etc.) • Cath Lab (heart attack, angioplasty/stent, etc.) • Heart Failure (including implantable device management, CardioMEMs, pacemaker, ICD, CRT) • Left Ventricular Assist Device (LVAD) • Diabetes (information and disease management) • General Heart Health Driven by a commitment to innovation, we have expanded our offerings to include solid organ transplant patient education, recognizing the need for tailored support in these complex medical journeys. Our Online Transplant Learning Center with TransplantPatientAI addresses the unique challenges faced by organ transplant recipients, providing them with the tools and knowledge to embark on their lifelong journey with confidence. Our transplant education platforms include: • Lung • Liver • Kidney • Heart (coming in Spring 2025) Through RecoverRite® and our AI-powered education platforms, we are reshaping the landscape of patient care, empowering individuals to take control of their health and ultimately improving outcomes for both patients and healthcare providers. Lets connect and revolutionize healthcare together.
2021
Salesforce Practice Sales & Mktg Partner
Oct 2021
Turnberry Solutions is a business and technology consulting and implementation firm that believes brilliant strategy only matters when paired with excellent execution. Through a deep understanding of each clients challenges and opportunities, we deliver tailored solutions and premium talent for sustainable, meaningful, and fearless growth. With offerings in business excellence, digital design and build, platforms of innovation, and AI, data, and insights, we set the best teams, technologies, and solutions in motion. At Turnberry, we welcome challenges and embrace complexity so that you can shape the future and reach your biggest goals. Whether you’re looking to grow your consulting career at a national Top Workplace or a future client, we’d love to tell you more. Check out our website turnberrysolutions.com for additional information.
2015
Sr. Sales Director - NE Region (Salesforce)
Jun 2015
Clients choose Acumen Solutions, a Salesforce Company, for one simple reason: our experience delivers success. Joining forces with our clients, our teams of strategists, subject matter experts, and engineers solve problems that can’t be fixed by technology alone. Fortune 500 companies trust us to build solutions that grow revenue and strengthen customer relationships while our groundbreaking solutions in the public sector streamline operations and improve productivity. We apply the same expertise to our unparalleled social responsibility program, generating sustainable impact across our local communities.
Show all 8 entries ↓
Investment activity
2023–2024 · 3 investments
2023120242
Recent (last 2 years)Earlier